Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
SeqLL Inc. Warrant (SQLLW)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/05/2025: SQLLW (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $0
1 Year Target Price $0
| 0 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -71.43% | Avg. Invested days 24 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 02/05/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 1.55 | 52 Weeks Range 0.00 - 0.02 | Updated Date 06/18/2025 |
52 Weeks Range 0.00 - 0.02 | Updated Date 06/18/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.41 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -31.78% | Operating Margin (TTM) -9.19% |
Management Effectiveness
Return on Assets (TTM) -16.95% | Return on Equity (TTM) -263.16% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 16364401 |
Shares Outstanding - | Shares Floating 16364401 | ||
Percent Insiders - | Percent Institutions - |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
SeqLL Inc. Warrant
Company Overview
History and Background
SeqLL Inc. is a life sciences instrumentation and reagent company. SeqLL Inc. Warrant relates to the opportunity to purchase shares of SeqLL Inc. at a predetermined price before the expiration date.
Core Business Areas
- Genomics & Sequencing: SeqLL Inc. focuses on single-molecule sequencing technology, developing instruments and reagents for research in genomics and transcriptomics.
Leadership and Structure
Information on the specific leadership team and organizational structure for SeqLL Inc. Warrant would be contingent on the details described in the formal documentation of the warrant.
Top Products and Market Share
Key Offerings
- True Single Molecule Sequencing (tSMS): SeqLL's primary offering is its platform for tSMS. The market share for this technology in relation to the broader sequencing market is still developing. Competitors include Illumina (ILMN), Pacific Biosciences (PACB), and Oxford Nanopore Technologies.
Market Dynamics
Industry Overview
The genomics and sequencing market is experiencing rapid growth, driven by advancements in technology and decreasing sequencing costs.
Positioning
SeqLL Inc. is positioned as a niche player offering a unique approach to single-molecule sequencing, differentiating itself from established players.
Total Addressable Market (TAM)
The total addressable market (TAM) for genomics and sequencing is estimated to be in the tens of billions of dollars. SeqLL's positioning allows it to compete within a segment of this TAM. Specific figures depend on the adoption rate of tSMS technology.
Upturn SWOT Analysis
Strengths
- Unique single-molecule sequencing technology
- Potential for high accuracy in sequencing
- Proprietary intellectual property
Weaknesses
- Limited market presence compared to established players
- Technology is still relatively new and requires further validation
- Potential liquidity or financial constrains
Opportunities
- Expanding into new applications of single-molecule sequencing
- Partnerships with research institutions and pharmaceutical companies
- Increasing demand for personalized medicine and genomics research
Threats
- Intense competition from established sequencing companies
- Rapid technological advancements making current technology obsolete
- Regulatory hurdles for diagnostic applications
Competitors and Market Share
Key Competitors
- ILMN
- PACB
- ONT.L
Competitive Landscape
SeqLL's advantages lie in its unique single-molecule sequencing approach, but it faces challenges in competing with the scale and market presence of larger, established competitors.
Growth Trajectory and Initiatives
Historical Growth: Historical growth is dependent on adoption of its sequencing technology.
Future Projections: Future projections are dependent on analyst estimates and market adoption, which are not available without real-time financial data and analyst reports.
Recent Initiatives: Recent initiatives would involve expanding sales and marketing efforts, developing new applications for its technology, and forming strategic partnerships.
Summary
SeqLL Inc. Warrant offers a speculative investment tied to the potential success of SeqLL's single-molecule sequencing technology. While SeqLL's unique technology presents opportunities, it faces significant competition and financial risks. The company needs to focus on expanding its market reach and securing strategic partnerships to thrive. Careful consideration of the inherent volatility of small-cap biotech warrants is crucial for potential investors.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company press releases
- Company website
- Market research reports
- Sec Filings
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Investment decisions should be based on thorough research and consultation with a qualified financial advisor. Market data is subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About SeqLL Inc. Warrant
Exchange NASDAQ | Headquaters Englewood Cliffs, NJ, United States | ||
IPO Launch date 2021-08-27 | CEO & Director Mr. Jeffrey M. Jagid | ||
Sector Industrials | Industry Staffing & Employment Services | Full time employees 300 | |
Full time employees 300 | |||
Atlantic International Corp. operates as a staffing company servicing the commercial, professional, finance, direct placement, and managed service provider verticals. The company specializes in permanent, temporary, and temporary-to-permanent placement services in various areas, including accounting and finance, administrative and clerical, hospitality, information technology, legal, light industrial, and medical fields. It provides productivity consulting and workforce management solutions. The company was founded in 2018 and is based in Englewood Cliffs, New Jersey.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.